Загрузка...
Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease.
A 69-year-old woman treated for 31 months with daily oral cyclophosphamide for refractory rheumatoid disease developed acute myelomonocytic leukemia 21/2 years after stopping the drug. The possibility of a casual association between the therapy and subsequent leukaemia is supported by the growing ex...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1975
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1006477/ https://ncbi.nlm.nih.gov/pubmed/1062969 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|